8 insiders reported 48 Form 4 transactions for Immunome Inc. (IMNM) over the past 18 months (most recent 2026-07-07). Recent activity: Barchas Isaac (Director) Sell 83,094 shares, Lechleider Robert (Chief Medical Officer) Buy 55,000 shares, Lechleider Robert (Chief Medical Officer) Sell 22,714 shares, Barchas Isaac (Director) Sell 16,906 shares, Lechleider Robert (Chief Medical Officer) Sell 16,214 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Barchas Isaac | Director | Sell | 83,094 | $2.0M |
| 2026-07-07 | Lechleider Robert | Chief Medical Officer | Buy | 55,000 | $480,150 |
| 2026-07-07 | Lechleider Robert | Chief Medical Officer | Sell | 22,714 | $498,572 |
| 2026-07-07 | Barchas Isaac | Director | Sell | 16,906 | $409,125 |
| 2026-07-07 | Lechleider Robert | Chief Medical Officer | Sell | 16,214 | $369,031 |
| 2026-07-07 | Lechleider Robert | Chief Medical Officer | Sell | 16,072 | $376,728 |
| 2026-07-02 | Barchas Isaac | Director | Sell | 101,050 | $2.1M |
| 2026-07-02 | Barchas Isaac | Director | Sell | 75,665 | $1.7M |
| 2026-07-02 | Barchas Isaac | Director | Sell | 24,335 | $567,736 |
| 2026-06-17 | Rosett Max | Chief Financial Officer | Buy | 60,000 | $63,000 |
| 2026-06-17 | Rosett Max | Chief Financial Officer | Sell | 60,000 | $1.1M |
| 2026-06-09 | BIENAIME JEAN JACQUES | Director | Buy | 6,000 | $116,880 |
| 2026-06-09 | BIENAIME JEAN JACQUES | Director | Sell | 500 | $9,720 |
| 2026-06-09 | BIENAIME JEAN JACQUES | Director | Buy | 3,500 | $68,110 |
| 2026-06-09 | BIENAIME JEAN JACQUES | Director | Buy | 1,000 | $19,270 |
| 2026-06-09 | BIENAIME JEAN JACQUES | Director | Sell | 10,000 | $194,100 |
| 2026-05-19 | BIENAIME JEAN JACQUES | Director | Buy | 5,000 | $103,500 |
| 2026-04-03 | Rosett Max | Chief Financial Officer | Buy | 31,848 | $33,440 |
| 2026-04-03 | Higgins Jack | Chief Scientific Officer | Sell | 9,438 | $204,238 |
| 2026-04-03 | Rosett Max | Chief Financial Officer | Sell | 63,656 | $1.4M |
| 2026-04-03 | Rosett Max | Chief Financial Officer | Sell | 1,344 | $30,213 |
| 2026-04-03 | Rosett Max | Chief Financial Officer | Buy | 39,713 | $53,613 |
| 2026-03-31 | SIEGALL CLAY B | President and CEO | Buy | 25,450 | $500,602 |
| 2026-03-23 | WAGENHEIM PHILIP | Director | Sell | 28,200 | $582,330 |
| 2026-03-23 | WAGENHEIM PHILIP | Director | Sell | 36,800 | $753,296 |
Source: SEC Form 4 filings · as of 2026-07-07